Total body PET/CT scans can successfully visualize systemic joint involvement in patients with autoimmune arthritis, according to new first-in-human research published in the October issue of the Journal of Nuclear Medicine. ...
Oct 13, 2022
0
4
A novel PET radiotracer can accurately assess the presence of a biomarker that indicates the level of tumor aggressiveness in neuroendocrine neoplasms (NENs). According to research published in the September issue of the ...
Sep 28, 2022
0
0
Artificial intelligence (AI) is showing significant promise in medical imaging. To translate this promise to reality requires rigorous evaluation of these algorithms.
Sep 13, 2022
0
24
In prostate cancer patients experiencing recurrence following a radical prostatectomy, imaging with 18F-DCFPyL PSMA PET/CT has been shown to considerably improve detection of active disease as compared to imaging with CT ...
Sep 7, 2022
0
19
Stimulator of interferon genes, or STING, helps regulate immune activation. Thus, a research team is testing drugs that activate STING as a form of cancer immunotherapy and for treating certain infections. Findings from ...
Aug 10, 2022
0
37
The Journal of Nuclear Medicine has published a first-hand account of the daily practice of nuclear medicine and molecular imaging during the ongoing war in Ukraine. In a "Discussions with Leaders" article, Yaroslav Kmetyuk, ...
Aug 1, 2022
0
6
Researchers have developed a noninvasive method to identify a potential cause of hypertension with a drastic reduction in radiation exposure, a study shows.
Jul 13, 2022
0
5
In a prospective study of young, lean adults, PET/CT imaging revealed that higher levels of active brown adipose tissue (also known as "brown fat") are more prevalent in individuals who exhibit very early indications of metabolic ...
May 6, 2022
0
25
A significant number of COVID-19 neurological complications— such as fatigue, headache, and cognitive impairment—are ultimately reversible, according to new research summarized by the Journal of Nuclear Medicine. The ...
Mar 17, 2022
0
101
A novel prostate cancer treatment—225Ac-PSMA-617 radioligand therapy—has been shown to increase the progression free survival (PFS) and overall survival (OS) of metastatic castration-resistant prostate cancer (mCRPC) ...
Mar 9, 2022
0
3
